Explain rationale behind classification for COVID-19 vaccination: Delhi HC to Centre
Delhi HC also asks Serum Institute, Bharat Biotech to disclose capacity to manufacture COVID-19 vaccines The Delhi High Court March 4 asked the Centre to explain the rationale behind keeping strict control over class of persons who can be vaccinated against COVID-19 currently as under the present system those above the age of 60 years or with comorbidities can receive vaccination. The High Court said the two institutes which have developed the vaccines Covishield and Covaxin — Serum Institute of India and Bharat Biotech — have more capacity to provide the vaccines but it seems that their...